Chemours Announces Dates for Second Quarter 2018 Earnings Release and Webcast Conference Call

WILMINGTON, Del., July 12, 2018 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced it will release second quarter financial results after market close on Thursday, August 2, 2018. The company will conduct its second quarter 2018 webcast conference call on Friday, August 3, 2018 at 8:30 a.m. Eastern Standard Time. The call is open to the public and can be accessed via live webcast and teleconference.

About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry.  Chemours is a global leader in fluoroproducts, chemical solutions, and titanium technologies, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.  Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing, and electronics. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™.  Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.  For more information please visit chemours.com.

CONTACT

MEDIA
Alvenia Scarborough
Sr. Director, Brand Marketing and Corporate Communications
+1.302.773.4507
media@chemours.com 

INVESTORS
Jonathan Lock
VP Corporate Development and Investor Relations
+1.302.773.2263
investor@chemours.com

View original content:http://www.prnewswire.com/news-releases/chemours-announces-dates-for-second-quarter-2018-earnings-release-and-webcast-conference-call-300678811.html

SOURCE The Chemours Company